A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma

We present results from the first phase III trial of once-daily tiotropium add-on to inhaled corticosteroids (ICS) plus one or more controller therapies in adolescents with severe symptomatic asthma. In this double-blind, parallel-group trial (NCT01277523), 392 patients aged 12–17 years were randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamelmann, Eckard, Bernstein, Jonathan A., Vandewalker, Mark, Moroni-Zentgraf, Petra, Verri, Daniela, Unseld, Anna, Engel, Michael, Boner, Attilio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298196/
https://www.ncbi.nlm.nih.gov/pubmed/27811070
http://dx.doi.org/10.1183/13993003.01100-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298196/
https://www.ncbi.nlm.nih.gov/pubmed/27811070
http://dx.doi.org/10.1183/13993003.01100-2016

Ejemplares similares